Cyclazodone: general
Cyclazodone is a synthetic stimulant from the oxazolone family, chemically related to pemoline and thozalinone[1][2]. It was developed by American Cyanamid Company in the 1960s as a central nervous system stimulant and anorectic — something meant to suppress appetite and increase alertness — and was described at the time as useful against fatigue and low mood[3][2]. It was never approved as a medicine anywhere, by the FDA or any other regulator[2][4].
The thing to know before anything else: there is no human data on cyclazodone. Not limited data — none. The only peer-reviewed paper on it is a 1967 note on rats, filed without even an abstract[4]. No human study exists in any retrievable form[4]. Nobody has published dose ranges, onset times, duration, or interaction data in people, and that is not an oversight — it has simply never been studied in humans.
If you use it anyway, that gap is the risk. Start far lower than seems reasonable, use a smaller amount than you'd guess from its relatives, and don't combine it with anything else, stimulant or otherwise, since there is no record of how it behaves in combination. Don't use it alone.
As with amphetamine-type stimulants generally, overdose is a real possibility with substances in this class, and what it looks like depends on the person, the drug, how it's taken, and the dose[5][6]. Excess dopamine and norepinephrine activity is described, in stimulants as a class, as producing heightened alertness, dilated pupils, fast heart rate, high blood pressure, overheating, and seizures, and severe cases can progress to cardiovascular collapse, organ failure, and death[7][8]. Supportive care for stimulant overdose — cooling, sedation, cardiovascular support — is the standard response[6]. None of this has been confirmed in cyclazodone specifically; it is what is known about the class it belongs to, applied to a substance that itself has never been tested in a person.
References
- Cyclazodone | C12H12N2O2 | CID 135438121 — PubChem, NIH
- Cyclazodone — Wikipedia
- US3313688A - Method of producing central nervous system stimulation and anorexia — Google Patents
- Cyclazodone: Evidence Ledger — Vialog
- Stimulant Guide: Overdose Prevention and Response — Centers for Disease Control and Prevention
- SAMHSA Overdose Prevention and Response Toolkit — Substance Abuse and Mental Health Services Administration
- Sympathomimetic Toxicity – StatPearls — NCBI Bookshelf
- Amphetamine Toxicity – StatPearls — NCBI Bookshelf
Comments
Sign in to join the conversation.
No comments yet.